MacroGenics CSO receives stock units and options
MacroGenics senior vice president and CSO Ezio Bonvini reported equity grants and related share activity.
Rhea-AI Filing Summary
MacroGenics senior vice president and CSO Ezio Bonvini reported equity grants and related share activity. On February 12, 2026 he received 31,250 restricted stock units and options for 187,500 shares at $1.71 per share, expiring February 12, 2036. On February 15, 2026 16,665 RSUs converted into common stock and 6,433 shares were withheld at $1.71 for taxes. After these transactions he directly holds 145,799 common shares and 31,250 RSUs.
Positive
- None.
Negative
- None.
Insider Trade Summary
16,665 shares exercised/converted
Exercise
5 txns
Insider
Bonvini Ezio
Role
Sr VP, Research & CSO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 16,665 | $0.00 | $0.00 |
| Exercise | Common Stock | 16,665 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 6,433 | $1.71 | $11K |
| Grant/Award | Restricted Stock Unit | 31,250 | $0.00 | $0.00 |
| Grant/Award | Employee Stock Option (right to buy) | 187,500 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Unit — 31,250 contracts (Direct);
Employee Stock Option (right to buy) — 187,500 contracts (Direct);
Common Stock — 145,799 shares (Direct)
Footnotes (3)
- F1. On February 15, 2023, the reporting person was granted 50,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis.
- F2. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.
- F3. 12.5% of the shares underlying the grant became exercisable one year after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.
Key Figures
RSU grant: 31,250 units
Stock options granted: 187,500 shares
Option exercise price: $1.7100 per share
+4 more
7 metrics
RSU grant
31,250 units
Restricted Stock Units granted on February 12, 2026
Stock options granted
187,500 shares
Employee Stock Option grant on February 12, 2026
Option exercise price
$1.7100 per share
Exercise price of Employee Stock Option grant
RSUs converted
16,665 shares
Restricted Stock Units converted to common stock on February 15, 2026
Shares withheld for taxes
6,433 shares
Common shares withheld at $1.71 per share on February 15, 2026
Common shares held
145,799 shares
Direct common stock holdings after reported transactions
RSUs held
31,250 units
Direct Restricted Stock Unit holdings after reported transactions
Key Terms
Restricted Stock Unit, Employee Stock Option, tax-withholding disposition
3 terms
Restricted Stock Unit financial
"On February 12, 2026 he received 31,250 restricted stock units"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Employee Stock Option financial
"Employee Stock Option (right to buy) for 187,500 shares at $1.71"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
tax-withholding disposition financial
"transaction_action: tax-withholding disposition of 6,433 shares"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did MacroGenics (MGNX) grant to Ezio Bonvini in February 2026?
Ezio Bonvini received 31,250 restricted stock units and employee stock options for 187,500 shares on February 12, 2026. The options carry an exercise price of $1.71 per share and are scheduled to expire on February 12, 2036.
What are the terms of Ezio Bonvini's MacroGenics (MGNX) stock options?
The employee stock options give a right to buy 187,500 shares of MacroGenics common stock at $1.71 per share. These options were granted on February 12, 2026 and have an expiration date of February 12, 2036, subject to their vesting terms.
How many RSUs converted to MacroGenics (MGNX) common stock for Ezio Bonvini?
On February 15, 2026, 16,665 restricted stock units held by Ezio Bonvini converted into MacroGenics common stock. Each RSU represents a contingent right to receive one share of common stock, so this conversion delivered the same number of shares.
What are Ezio Bonvini’s post-transaction holdings in MacroGenics (MGNX)?
After the reported transactions, Ezio Bonvini directly holds 145,799 shares of MacroGenics common stock and 31,250 restricted stock units. These holdings reflect his remaining equity position following the February 2026 grants, RSU conversion, and tax-share withholding.
AI-generated analysis. How Rhea-AI works. Not financial advice.
